(+)-Tetrandrine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 tetrandrine results in increased expression of MAP1LC3B CTD PMID:26822499 (-)-demecolcine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Demecolcine results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAP1LC3B mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 epigallocatechin gallate results in increased expression of MAP1LC3B protein CTD PMID:32512070 (1->4)-beta-D-glucan multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP1LC3B mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO Map1lc3b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of MAP1LC3B mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3B mRNA CTD PMID:22206623 1,3-dichloropropan-2-ol decreases expression EXP 6480464 1 and 3-dichloro-2-propanol results in decreased expression of MAP1LC3B protein CTD PMID:36000575 1-monopalmitoylglycerol increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 palmitoyl glycerol results in increased lipidation of MAP1LC3B protein CTD PMID:37466199 1-monopalmitoylglycerol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine promotes the reaction [palmitoyl glycerol results in increased lipidation of MAP1LC3B protein] CTD PMID:37466199 1-nitropyrene increases expression ISO MAP1LC3B (Homo sapiens) 6480464 1-nitropyrene results in increased expression of MAP1LC3B mRNA and 1-nitropyrene results in increased expression of MAP1LC3B protein CTD PMID:29078374 1-nitropyrene multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG7 protein affects the reaction [1-nitropyrene results in increased expression of MAP1LC3B protein] CTD PMID:29078374 1-nitropyrene increases expression ISO Map1lc3b (Mus musculus) 6480464 1-nitropyrene results in increased expression of MAP1LC3B mRNA and 1-nitropyrene results in increased expression of MAP1LC3B protein CTD PMID:29078374 17alpha-ethynylestradiol affects expression ISO Map1lc3b (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of MAP1LC3B mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MAP1LC3B mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO Map1lc3b (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of MAP1LC3B mRNA CTD PMID:17942748 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [2 more ... CTD PMID:29518472 2,2',5,5'-tetrachlorobiphenyl increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 2 more ... CTD PMID:29518472 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [2 more ... CTD PMID:29518472 2,2',5,5'-tetrachlorobiphenyl increases cleavage EXP 6480464 2 more ... CTD PMID:29518472 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene affects expression ISO Map1lc3b (Mus musculus) 6480464 2 more ... CTD PMID:32721735 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP1LC3B mRNA CTD PMID:16054898 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP1LC3B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map1lc3b (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3B mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3B mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Map1lc3b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP1LC3B mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MAP1LC3B mRNA CTD PMID:17942748 2,4,6-trinitrobenzenesulfonic acid increases lipidation EXP 6480464 Trinitrobenzenesulfonic Acid results in increased lipidation of MAP1LC3B protein CTD PMID:30503585 2,4,6-trinitrobenzenesulfonic acid multiple interactions EXP 6480464 Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased lipidation of MAP1LC3B protein] CTD PMID:30503585 2,4-D multiple interactions EXP 6480464 lycium barbarum polysaccharide inhibits the reaction [2 and 4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA] CTD PMID:34464015 2,4-D multiple interactions ISO Map1lc3b (Mus musculus) 6480464 lycium barbarum polysaccharide inhibits the reaction [2 more ... CTD PMID:35099110 2,4-D decreases expression ISO Map1lc3b (Mus musculus) 6480464 2 and 4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA CTD PMID:35099110 2,4-D affects localization ISO Map1lc3b (Mus musculus) 6480464 2 and 4-Dichlorophenoxyacetic Acid affects the localization of MAP1LC3B protein CTD PMID:35099110 2,4-D decreases expression EXP 6480464 2 and 4-Dichlorophenoxyacetic Acid results in decreased expression of MAP1LC3B mRNA CTD PMID:34464015 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 buprofezin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:36287832 2-amino-14,16-dimethyloctadecan-3-ol increases expression ISO MAP1LC3B (Homo sapiens) 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in increased expression of MAP1LC3B protein modified form CTD PMID:32044396 2-deoxy-D-glucose multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 ATG7 protein promotes the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] more ... CTD PMID:20593179 2-deoxy-D-glucose increases prenylation ISO MAP1LC3B (Homo sapiens) 6480464 Deoxyglucose results in increased prenylation of MAP1LC3B protein CTD PMID:20593179 2-hydroxyethyl methacrylate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 hydroxyethyl methacrylate results in increased expression of MAP1LC3B mRNA and hydroxyethyl methacrylate results in increased expression of MAP1LC3B protein CTD PMID:28184909 2-hydroxyethyl methacrylate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B mRNA] and 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [hydroxyethyl methacrylate results in increased expression of MAP1LC3B protein] CTD PMID:28184909 3,3',5-triiodo-L-thyronine increases expression ISO Map1lc3b (Mus musculus) 6480464 Triiodothyronine results in increased expression of MAP1LC3B mRNA CTD PMID:30209975 3,3',5-triiodo-L-thyronine increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Triiodothyronine results in increased lipidation of MAP1LC3B protein CTD PMID:30209975 3,3',5-triiodo-L-thyronine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 bafilomycin A1 promotes the reaction [Triiodothyronine results in increased lipidation of MAP1LC3B protein] and Triiodothyronine promotes the reaction [bafilomycin A1 results in increased lipidation of MAP1LC3B protein] CTD PMID:30209975 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MAP1LC3B mRNA CTD PMID:30071829 3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(propan-2-yl)-1H-indol-2-yl]-2,2-dimethylpropanoic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MK-886 inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] CTD PMID:30677399 3-chloropropane-1,2-diol increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 alpha-Chlorohydrin results in increased lipidation of MAP1LC3B protein CTD PMID:35149085 3-chloropropane-1,2-diol multiple interactions EXP 6480464 [alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein and alpha-Chlorohydrin inhibits the reaction [Diosgenin results in decreased lipidation of MAP1LC3B protein] CTD PMID:35149085 3-chloropropane-1,2-diol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35149085 3-methyladenine multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [2 more ... CTD PMID:18640276 more ... 3-methyladenine increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine results in increased lipidation of MAP1LC3B protein CTD PMID:34281243 3-methyladenine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 3-methyladenine decreases expression EXP 6480464 3-methyladenine results in decreased expression of MAP1LC3B mRNA CTD PMID:30611790 3-methyladenine decreases cleavage ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine results in decreased cleavage of MAP1LC3B protein CTD PMID:26804720 3-methyladenine affects metabolic processing ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine affects the metabolism of MAP1LC3B protein CTD PMID:23680031 3-methyladenine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine affects the reaction [T-2 Toxin affects the expression of MAP1LC3B protein] more ... CTD PMID:21325019 more ... 3-methyladenine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine affects the reaction [Alpha-Amanitin affects the lipidation of MAP1LC3B protein] more ... CTD PMID:20962572 more ... 3-methyladenine decreases expression ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine results in decreased expression of MAP1LC3B mRNA and 3-methyladenine results in decreased expression of MAP1LC3B protein modified form CTD PMID:21681844 and PMID:32512069 3-Nitrofluoranthene increases expression ISO Map1lc3b (Mus musculus) 6480464 3-nitrofluoranthene results in increased expression of MAP1LC3B protein CTD PMID:19041363 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1 and 2-dithiol-3-thione results in decreased expression of MAP1LC3B mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO Map1lc3b (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of MAP1LC3B mRNA CTD PMID:18648102 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 4 more ... CTD PMID:37156403 4-hydroxynon-2-enal increases expression ISO Map1lc3b (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of MAP1LC3B mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Fenretinide results in increased expression of MAP1LC3B mRNA CTD PMID:16671099 4-hydroxyphenyl retinamide increases expression ISO Map1lc3b (Mus musculus) 6480464 Fenretinide results in increased expression of MAP1LC3B mRNA CTD PMID:28973697 4-methoxy-TEMPO increases metabolic processing ISO MAP1LC3B (Homo sapiens) 6480464 4-methoxy-2 more ... CTD PMID:28993908 4-phenylbutyric acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] CTD PMID:26804720 4-phenylbutyric acid decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 4-phenylbutyric acid results in decreased expression of MAP1LC3B protein CTD PMID:36640941 4-phenylbutyric acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 4-phenylbutyric acid inhibits the reaction [Curcumin results in decreased expression of MAP1LC3B protein] more ... CTD PMID:30025493 more ... 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] CTD PMID:26804720 5-aza-2'-deoxycytidine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Decitabine inhibits the reaction [Rotenone results in increased lipidation of and results in increased cleavage of MAP1LC3B protein] and Decitabine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] CTD PMID:19577553 and PMID:30673822 5-fluorouracil affects response to substance ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B protein affects the susceptibility to Fluorouracil CTD PMID:15548681 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 6-chloro-2 more ... CTD PMID:24145604 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 7-ketocholesterol increases expression ISO Map1lc3b (Mus musculus) 6480464 7-ketocholesterol results in increased expression of MAP1LC3B protein CTD PMID:24445604 7-ketocholesterol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 CD38 gene mutant form promotes the reaction [7-ketocholesterol results in increased expression of MAP1LC3B protein] CTD PMID:24445604 abamectin increases expression EXP 6480464 abamectin results in increased expression of MAP1LC3B mRNA CTD PMID:34748272 abamectin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3B mRNA] CTD PMID:34748272 ABT-737 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP3 protein] more ... CTD PMID:20104024 acadesine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 acadesine promotes the reaction [Artesunate results in increased lipidation of MAP1LC3B protein] CTD PMID:33002460 acetaldehyde increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Acetaldehyde results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 acetaldehyde multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Cyanamide promotes the reaction [Acetaldehyde results in increased lipidation of MAP1LC3B protein] CTD PMID:24492484 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of MAP1LC3B mRNA CTD PMID:31881176 acrolein increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Acrolein results in increased lipidation of MAP1LC3B protein CTD PMID:34238121 acrolein multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Acrolein results in increased lipidation of MAP1LC3B protein] and ATG7 protein affects the reaction [Acrolein results in increased lipidation of MAP1LC3B protein] CTD PMID:34238121 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of MAP1LC3B mRNA CTD PMID:28959563 acrylamide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acrylamide results in increased expression of and results in increased lipidation of MAP1LC3B protein and TFEB protein inhibits the reaction [Acrylamide results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:37172712 acrylamide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Acrylamide results in increased expression of MAP1LC3B mRNA CTD PMID:32763439 actinomycin D multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Dactinomycin inhibits the reaction [Ethanol results in increased expression of MAP1LC3B protein] CTD PMID:24095927 aflatoxin B1 increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of MAP1LC3B mRNA CTD PMID:27153756 aflatoxin B1 increases expression ISO Map1lc3b (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of MAP1LC3B mRNA and Aflatoxin B1 results in increased expression of MAP1LC3B protein CTD PMID:35304092 and PMID:35810998 aflatoxin B1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 PRKN protein affects the reaction [Aflatoxin B1 results in increased expression of MAP1LC3B mRNA] CTD PMID:35304092 aldehydo-D-glucose multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 and PMID:35243728 aldehydo-D-glucose decreases lipidation EXP 6480464 Glucose results in decreased lipidation of MAP1LC3B protein CTD PMID:35243728 aldehydo-D-glucose increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Glucose deficiency results in increased expression of MAP1LC3B protein and Glucose deficiency results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 aldehydo-D-glucose multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form] CTD PMID:34580807 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of MAP1LC3B protein CTD PMID:29128638 aldrin decreases expression ISO Map1lc3b (Mus musculus) 6480464 Aldrin results in decreased expression of MAP1LC3B mRNA CTD PMID:18579281 alginic acid increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Alginic Acid results in increased lipidation of MAP1LC3B protein CTD PMID:35066102 all-trans-retinoic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 ATG5 protein affects the reaction [Tretinoin results in increased metabolism of and affects the localization of MAP1LC3B protein] more ... CTD PMID:28978663 and PMID:29743969 all-trans-retinoic acid increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Tretinoin results in increased expression of MAP1LC3B mRNA CTD PMID:29743969 and PMID:33167477 allethrin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Allethrins results in increased lipidation of MAP1LC3B protein CTD PMID:36528879 aloxistatin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:26483381 and PMID:27635674 aloxistatin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 aloxistatin results in increased lipidation of MAP1LC3B protein CTD PMID:33124469 aloxistatin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:27635674 more ... alpha,alpha-trehalose multiple interactions ISO Map1lc3b (Mus musculus) 6480464 TFEB affects the reaction [Trehalose results in increased expression of MAP1LC3B mRNA] CTD PMID:30335591 alpha,alpha-trehalose increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Trehalose results in increased cleavage of MAP1LC3B protein CTD PMID:29486218 alpha,alpha-trehalose increases expression ISO Map1lc3b (Mus musculus) 6480464 Trehalose results in increased expression of MAP1LC3B mRNA CTD PMID:30335591 alpha-amanitin multiple interactions EXP 6480464 Alpha-Amanitin results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:37329965 alpha-amanitin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine affects the reaction [Alpha-Amanitin affects the lipidation of MAP1LC3B protein] and Alpha-Amanitin inhibits the reaction [dorsomorphin results in decreased lipidation of MAP1LC3B protein] CTD PMID:37329965 alpha-amanitin affects lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Alpha-Amanitin affects the lipidation of MAP1LC3B protein CTD PMID:37329965 Alpinetin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [TNF protein results in increased expression of and results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:31676321 Alpinetin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:31676321 aluminium atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:34547296 aluminium(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:34547296 amiodarone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Amiodarone results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:25881747 amiodarone increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Amiodarone results in increased lipidation of MAP1LC3B protein CTD PMID:32651653 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP1LC3B mRNA CTD PMID:16483693 ammonium chloride increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Ammonium Chloride results in increased expression of MAP1LC3B protein CTD PMID:35504338 ammonium chloride increases expression ISO Map1lc3b (Mus musculus) 6480464 Ammonium Chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:31310755 ammonium chloride increases metabolic processing ISO MAP1LC3B (Homo sapiens) 6480464 Ammonium Chloride results in increased metabolism of MAP1LC3B protein CTD PMID:29908302 ammonium chloride multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 bafilomycin A1 affects the reaction [Ammonium Chloride results in increased metabolism of MAP1LC3B protein] and NR1I2 protein affects the reaction [Ammonium Chloride results in increased metabolism of MAP1LC3B protein] CTD PMID:29908302 ammonium chloride increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Ammonium Chloride results in increased lipidation of MAP1LC3B protein CTD PMID:31927068 amphotericin B increases expression ISO Map1lc3b (Mus musculus) 6480464 Amphotericin B results in increased expression of MAP1LC3B protein CTD PMID:23988732 amsacrine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Amsacrine results in increased expression of MAP1LC3B protein CTD PMID:37451322 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein] CTD PMID:35130734 antimycin A increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Antimycin A results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 apigenin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] and Glutathione inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] CTD PMID:29247770 apigenin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Apigenin results in increased expression of MAP1LC3B protein modified form CTD PMID:29247770 apocynin multiple interactions EXP 6480464 acetovanillone analog inhibits the reaction [Chlorpyrifos results in increased lipidation of MAP1LC3B protein] CTD PMID:29859868 aristolochic acid A increases expression ISO MAP1LC3B (Homo sapiens) 6480464 aristolochic acid I results in increased expression of MAP1LC3B mRNA CTD PMID:33212167 arsane increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Arsenic results in increased expression of MAP1LC3B protein and Arsenic results in increased expression of MAP1LC3B protein modified form CTD PMID:27413109 and PMID:29248574 arsane multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP1LC3B mRNA CTD PMID:31844926 arsane multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29248574 and PMID:32525701 arsane increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic results in increased expression of MAP1LC3B protein CTD PMID:27413109 arsenic atom increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Arsenic results in increased expression of MAP1LC3B protein and Arsenic results in increased expression of MAP1LC3B protein modified form CTD PMID:27413109 and PMID:29248574 arsenic atom multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP1LC3B mRNA CTD PMID:31844926 arsenic atom multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29248574 and PMID:32525701 arsenic atom increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic results in increased expression of MAP1LC3B protein CTD PMID:27413109 arsenite(3-) multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:33097607 and PMID:34929507 arsenite(3-) increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 arsenite results in increased lipidation of MAP1LC3B protein CTD PMID:34929507 arsenous acid multiple interactions EXP 6480464 [ferrostatin-1 co-treated with Arsenic Trioxide] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29111283 and PMID:35195477 arsenous acid increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 arsenous acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] more ... CTD PMID:28978663 more ... arsenous acid increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA more ... CTD PMID:29307831 more ... arsenous acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA and Arsenic Trioxide results in increased expression of MAP1LC3B protein CTD PMID:30032600 more ... arsenous acid increases lipidation EXP 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 arsenous acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 arsenous acid increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 arsenous acid increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 artesunate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Artesunate results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:33002460 artesunate increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Artesunate results in increased lipidation of MAP1LC3B protein CTD PMID:33002460 atazanavir sulfate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Atazanavir Sulfate results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 atazanavir sulfate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 atorvastatin calcium multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein] CTD PMID:34939712 atrazine increases expression ISO Map1lc3b (Mus musculus) 6480464 Atrazine results in increased expression of MAP1LC3B protein CTD PMID:25259610 and PMID:33485040 atrazine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Atrazine results in increased expression of MAP1LC3B protein] CTD PMID:25259610 auramine O multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 ALDH1A1 protein promotes the reaction [Benzophenoneidum results in increased lipidation of and results in increased cleavage of MAP1LC3B protein] and Benzophenoneidum results in increased lipidation of and results in increased cleavage of MAP1LC3B protein CTD PMID:28722353 AZD4547 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 bafilomycin A1 affects the reaction [AZD4547 affects the expression of MAP1LC3B protein modified form] CTD PMID:26853465 AZD4547 affects expression ISO MAP1LC3B (Homo sapiens) 6480464 AZD4547 affects the expression of MAP1LC3B protein modified form CTD PMID:26853465 bafilomycin A1 increases expression ISO MAP1LC3B (Homo sapiens) 6480464 bafilomycin A1 results in increased expression of MAP1LC3B protein more ... CTD PMID:24145604 more ... bafilomycin A1 increases lipidation EXP 6480464 bafilomycin A1 results in increased lipidation of MAP1LC3B protein CTD PMID:32525084 bafilomycin A1 multiple interactions EXP 6480464 [Doxorubicin co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein more ... CTD PMID:32278738 more ... bafilomycin A1 increases expression EXP 6480464 bafilomycin A1 results in increased expression of MAP1LC3B protein modified form CTD PMID:32278738 bafilomycin A1 increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 bafilomycin A1 results in increased lipidation of MAP1LC3B protein CTD PMID:33124469 more ... bafilomycin A1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:30209975 more ... bafilomycin A1 increases lipidation ISO Map1lc3b (Mus musculus) 6480464 bafilomycin A1 results in increased lipidation of MAP1LC3B protein CTD PMID:30209975 bafilomycin A1 increases expression ISO Map1lc3b (Mus musculus) 6480464 bafilomycin A1 results in increased expression of MAP1LC3B protein modified form CTD PMID:31310755 bafilomycin A1 increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 bafilomycin A1 results in increased cleavage of MAP1LC3B protein CTD PMID:29248574 bafilomycin A1 decreases degradation EXP 6480464 bafilomycin A1 results in decreased degradation of MAP1LC3B protein modified form CTD PMID:26459185 bafilomycin A1 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [bafilomycin A1 co-treated with Miconazole] results in increased expression of MAP1LC3B protein more ... CTD PMID:23880069 more ... Bafilomycin B1 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Rotenone co-treated with bafilomycin B1] results in increased lipidation of and results in increased cleavage of MAP1LC3B protein CTD PMID:30673822 Bafilomycin B1 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 bafilomycin B1 promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form] and Cisplatin promotes the reaction [bafilomycin B1 results in increased expression of MAP1LC3B protein modified form] CTD PMID:32738330 Bafilomycin B1 increases expression ISO Map1lc3b (Mus musculus) 6480464 bafilomycin B1 results in increased expression of MAP1LC3B protein modified form CTD PMID:32738330 BAPTA multiple interactions ISO Map1lc3b (Mus musculus) 6480464 1 more ... CTD PMID:37981210 belinostat increases expression ISO MAP1LC3B (Homo sapiens) 6480464 belinostat results in increased expression of MAP1LC3B mRNA CTD PMID:19606018 benzo[a]pyrene increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MAP1LC3B mRNA CTD PMID:22316170 benzo[a]pyrene increases lipidation EXP 6480464 Benzo(a)pyrene results in increased lipidation of MAP1LC3B protein CTD PMID:32619457 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with Resveratrol] promotes the reaction [MAP1LC3B protein binds to TOMM20 protein] more ... CTD PMID:32619457 benzo[a]pyrene increases expression ISO Map1lc3b (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of MAP1LC3B mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO MAP1LC3B (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20382639 berberine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Berberine co-treated with Cisplatin] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:36070022 berberine increases localization EXP 6480464 Berberine results in increased localization of MAP1LC3B protein CTD PMID:35439518 berberine multiple interactions EXP 6480464 Berberine inhibits the reaction [Chlorpyrifos results in decreased expression of MAP1LC3B mRNA] CTD PMID:35439518 beta-ionone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [beta-ionone results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:36843289 beta-lapachone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 beta-lapachone affects the localization of and results in increased metabolism of MAP1LC3B protein CTD PMID:21035436 betulinic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Erlotinib Hydrochloride promotes the reaction [Betulinic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:30136359 betulinic acid increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Betulinic Acid results in increased expression of MAP1LC3B protein modified form CTD PMID:30136359 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of MAP1LC3B protein CTD PMID:29606031 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP1LC3B mRNA CTD PMID:25181051 bisphenol A increases lipidation EXP 6480464 bisphenol A results in increased lipidation of MAP1LC3B protein CTD PMID:31551937 bisphenol A multiple interactions ISO Map1lc3b (Mus musculus) 6480464 bisphenol A results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:34281243 bisphenol A affects localization EXP 6480464 bisphenol A affects the localization of MAP1LC3B protein CTD PMID:38006930 bisphenol A multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [bisphenol A co-treated with 3-methyladenine] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:34281243 bisphenol A affects splicing ISO Map1lc3b (Mus musculus) 6480464 bisphenol A affects the splicing of MAP1LC3B mRNA CTD PMID:37894381 bisphenol A affects localization ISO MAP1LC3B (Homo sapiens) 6480464 bisphenol A affects the localization of MAP1LC3B protein CTD PMID:38006930 bisphenol A affects expression ISO MAP1LC3B (Homo sapiens) 6480464 bisphenol A affects the expression of MAP1LC3B mRNA CTD PMID:30903817 bisphenol A increases expression ISO MAP1LC3B (Homo sapiens) 6480464 bisphenol A results in increased expression of MAP1LC3B protein CTD PMID:29275510 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP1LC3B protein modified form CTD PMID:27539358 bisphenol A increases methylation ISO Map1lc3b (Mus musculus) 6480464 bisphenol A results in increased methylation of MAP1LC3B promoter CTD PMID:27312807 Bisphenol B increases expression ISO MAP1LC3B (Homo sapiens) 6480464 bisphenol B results in increased expression of MAP1LC3B protein CTD PMID:34186270 bisphenol F increases expression ISO MAP1LC3B (Homo sapiens) 6480464 bisphenol F results in increased expression of MAP1LC3B protein CTD PMID:34186270 bleomycin A2 increases expression ISO Map1lc3b (Mus musculus) 6480464 Bleomycin results in increased expression of MAP1LC3B protein modified form CTD PMID:31302203 bleomycin A2 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Soot inhibits the reaction [Bleomycin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31302203 bortezomib multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B protein affects the reaction [Bortezomib results in increased phosphorylation of NFKBIA protein] CTD PMID:24085292 brefeldin A multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [aloxistatin co-treated with pepstatin] promotes the reaction [Brefeldin A results in increased expression of and results in increased lipidation of MAP1LC3B protein] and Brefeldin A results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32397857 buprofezin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 buprofezin results in increased lipidation of and results in increased localization of MAP1LC3B protein CTD PMID:36287832 buspirone increases expression EXP 6480464 Buspirone results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 butachlor increases expression ISO Map1lc3b (Mus musculus) 6480464 butachlor results in increased expression of MAP1LC3B protein CTD PMID:34351278 butanal increases expression ISO MAP1LC3B (Homo sapiens) 6480464 butyraldehyde results in increased expression of MAP1LC3B mRNA CTD PMID:26079696 butein multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [butein results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35130734 butein increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 butein results in increased lipidation of MAP1LC3B protein CTD PMID:35130734 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of MAP1LC3B mRNA CTD PMID:19167457 cadmium atom increases expression ISO Map1lc3b (Mus musculus) 6480464 Cadmium results in increased expression of MAP1LC3B mRNA and Cadmium results in increased expression of MAP1LC3B protein modified form CTD PMID:19126599 more ... cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP1LC3B protein more ... CTD PMID:27872163 and PMID:32347499 cadmium atom multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased metabolism of MAP1LC3B protein more ... CTD PMID:31319114 cadmium atom affects localization ISO Map1lc3b (Mus musculus) 6480464 Cadmium affects the localization of MAP1LC3B protein CTD PMID:29111403 cadmium atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-(2 more ... CTD PMID:27492225 more ... cadmium dichloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-(2 more ... CTD PMID:21325019 more ... cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MAP1LC3B protein CTD PMID:27872163 cadmium dichloride multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 2-aminoethoxydiphenyl borate inhibits the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:25639782 more ... cadmium dichloride increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Cadmium Chloride results in increased cleavage of MAP1LC3B protein CTD PMID:29486218 cadmium dichloride increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MAP1LC3B protein and Cadmium Chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:25639782 and PMID:34580807 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form CTD PMID:21325019 cadmium dichloride increases expression ISO Map1lc3b (Mus musculus) 6480464 Cadmium Chloride results in increased expression of MAP1LC3B protein and Cadmium Chloride results in increased expression of MAP1LC3B protein alternative form CTD PMID:21325019 and PMID:35843418 caffeine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-(2 more ... CTD PMID:30555576 caffeine increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 Caffeine results in increased cleavage of MAP1LC3B protein CTD PMID:30555576 caffeine increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Caffeine results in increased cleavage of MAP1LC3B protein CTD PMID:30555576 caffeine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Caffeine results in increased cleavage of MAP1LC3B protein] more ... CTD PMID:30555576 calcidiol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Calcifediol inhibits the reaction [TNF protein promotes the reaction [BNIP3 protein binds to MAP1LC3B protein]] and Calcifediol inhibits the reaction [TNF protein results in increased expression of MAP1LC3B protein] CTD PMID:34255241 calix[6]arene increases expression ISO MAP1LC3B (Homo sapiens) 6480464 calix(6)arene results in increased expression of MAP1LC3B protein modified form CTD PMID:23872419 Calpeptin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 calpeptin inhibits the reaction [dehydroeburicoic acid affects the localization of MAP1LC3B protein] and calpeptin inhibits the reaction [dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine]] CTD PMID:19848398 capivasertib increases expression ISO MAP1LC3B (Homo sapiens) 6480464 capivasertib results in increased expression of MAP1LC3B protein modified form CTD PMID:26853465 capivasertib multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 bafilomycin A1 promotes the reaction [capivasertib results in increased expression of MAP1LC3B protein modified form] CTD PMID:26853465 carbamazepine multiple interactions EXP 6480464 [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of MAP1LC3B mRNA CTD PMID:35786680 carbon disulfide decreases expression ISO Map1lc3b (Mus musculus) 6480464 Carbon Disulfide results in decreased expression of MAP1LC3B mRNA and Carbon Disulfide results in decreased expression of MAP1LC3B protein CTD PMID:31369747 carbon disulfide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B mRNA] and N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B protein] CTD PMID:31369747 carbon nanotube increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of MAP1LC3B protein CTD PMID:24389112 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:32951350 carbon nanotube increases expression ISO Map1lc3b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:24929217 and PMID:25620056 carbon nanotube decreases expression ISO Map1lc3b (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carglumic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B mRNA] and N-carbamylglutamate inhibits the reaction [Carbon Disulfide results in decreased expression of MAP1LC3B protein] CTD PMID:31369747 carteolol affects localization ISO MAP1LC3B (Homo sapiens) 6480464 Carteolol affects the localization of MAP1LC3B protein CTD PMID:37120125 celecoxib multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B mutant form promotes the reaction [[Celecoxib co-treated with ABT-737] results in increased cleavage of CASP3 protein] more ... CTD PMID:20104024 CGP 52608 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP1LC3B gene] CTD PMID:28238834 CGS-21680 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Caffeine results in increased cleavage of MAP1LC3B protein] CTD PMID:30555576 chenodeoxycholic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Chenodeoxycholic Acid results in increased expression of MAP1LC3B protein CTD PMID:24189133 chenodeoxycholic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 chloropicrin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 chloropicrin results in increased expression of MAP1LC3B mRNA CTD PMID:26352163 chloroquine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Ethanol co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:24492484 more ... chloroquine increases expression ISO Map1lc3b (Mus musculus) 6480464 Chloroquine results in increased expression of MAP1LC3B protein and Chloroquine results in increased expression of MAP1LC3B protein modified form CTD PMID:25884947 and PMID:31310755 chloroquine affects localization ISO Map1lc3b (Mus musculus) 6480464 Chloroquine affects the localization of MAP1LC3B protein CTD PMID:30208301 chloroquine increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine results in increased cleavage of MAP1LC3B protein CTD PMID:29248574 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]] more ... CTD PMID:29476062 more ... chloroquine increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine results in increased lipidation of MAP1LC3B protein CTD PMID:23880069 more ... chloroquine decreases degradation ISO Map1lc3b (Mus musculus) 6480464 Chloroquine results in decreased degradation of MAP1LC3B protein modified form CTD PMID:32861759 chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of MAP1LC3B mRNA more ... CTD PMID:17643062 more ... chloroquine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine results in increased expression of MAP1LC3B mRNA more ... CTD PMID:24095927 more ... chloroquine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [4-nitrochalcone co-treated with Chloroquine] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:23880069 more ... chloroquine increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Chloroquine results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 and PMID:30301768 chlorpyrifos increases lipidation EXP 6480464 Chlorpyrifos results in increased lipidation of MAP1LC3B protein CTD PMID:29859868 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of MAP1LC3B mRNA CTD PMID:35439518 chlorpyrifos decreases localization EXP 6480464 Chlorpyrifos results in decreased localization of MAP1LC3B protein CTD PMID:35439518 chlorpyrifos increases expression ISO Map1lc3b (Mus musculus) 6480464 Chlorpyrifos results in increased expression of MAP1LC3B mRNA CTD PMID:37019170 chlorpyrifos multiple interactions EXP 6480464 acetovanillone analog inhibits the reaction [Chlorpyrifos results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:29859868 and PMID:35439518 cholesterol increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Cholesterol results in increased expression of MAP1LC3B protein modified form CTD PMID:28275691 cholesterol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Cholesterol inhibits the reaction [Cadmium Chloride results in increased cleavage of MAP1LC3B protein] CTD PMID:29486218 cholic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Cholic Acid results in increased expression of MAP1LC3B protein CTD PMID:24189133 chromium(6+) increases expression ISO MAP1LC3B (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of MAP1LC3B mRNA CTD PMID:30690063 chromium(6+) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [chromium hexavalent ion affects the expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:36739042 chrysin multiple interactions EXP 6480464 chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein] and chrysin inhibits the reaction [Colistin results in increased expression of MAP1LC3B protein] CTD PMID:28682524 and PMID:30273961 ciguatoxin CTX1B affects expression ISO Map1lc3b (Mus musculus) 6480464 Ciguatoxins affects the expression of MAP1LC3B mRNA CTD PMID:18353800 cisplatin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Berberine co-treated with Cisplatin] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:21191146 more ... cisplatin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Cisplatin results in increased lipidation of MAP1LC3B protein CTD PMID:36070022 cisplatin increases expression ISO Map1lc3b (Mus musculus) 6480464 Cisplatin results in increased expression of MAP1LC3B protein and Cisplatin results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 more ... cisplatin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG7 gene mutant form inhibits the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:29476062 more ... cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 cisplatin multiple interactions EXP 6480464 Chloroquine promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form] and Pentoxifylline inhibits the reaction [Cisplatin results in decreased expression of MAP1LC3B protein modified form] CTD PMID:29476062 and PMID:32777238 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAP1LC3B protein modified form CTD PMID:32777238 cisplatin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Cisplatin results in increased expression of MAP1LC3B mRNA more ... CTD PMID:19561079 more ... Citreoviridin multiple interactions EXP 6480464 Rosiglitazone inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:31419397 Citreoviridin increases expression ISO Map1lc3b (Mus musculus) 6480464 citreoviridin results in increased expression of MAP1LC3B protein modified form CTD PMID:31419397 Citreoviridin increases expression EXP 6480464 citreoviridin results in increased expression of MAP1LC3B protein modified form CTD PMID:31419397 Citreoviridin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] and Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 clobetasol increases expression ISO Map1lc3b (Mus musculus) 6480464 Clobetasol results in increased expression of MAP1LC3B mRNA CTD PMID:27462272 clofibrate decreases expression ISO Map1lc3b (Mus musculus) 6480464 Clofibrate results in decreased expression of MAP1LC3B mRNA CTD PMID:17585979 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of MAP1LC3B mRNA CTD PMID:21318169 clozapine increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Clozapine results in increased lipidation of MAP1LC3B protein CTD PMID:36482696 clozapine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Chloroquine co-treated with Clozapine] results in increased lipidation of MAP1LC3B protein CTD PMID:36482696 cobalt dichloride increases expression ISO MAP1LC3B (Homo sapiens) 6480464 cobaltous chloride results in increased expression of MAP1LC3B mRNA CTD PMID:19320972 and PMID:19376846 colistin multiple interactions EXP 6480464 chrysin inhibits the reaction [Colistin results in increased expression of MAP1LC3B protein] more ... CTD PMID:30273961 and PMID:30318960 colistin increases expression EXP 6480464 Colistin results in increased expression of MAP1LC3B mRNA and Colistin results in increased expression of MAP1LC3B protein CTD PMID:30273961 and PMID:30318960 copper atom multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA more ... CTD PMID:20971185 more ... copper atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:15467011 and PMID:31491480 copper(0) multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA more ... CTD PMID:20971185 more ... copper(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:15467011 and PMID:31491480 copper(II) chloride increases expression ISO MAP1LC3B (Homo sapiens) 6480464 cupric chloride results in increased expression of MAP1LC3B mRNA CTD PMID:17211630 copper(II) chloride increases lipidation ISO Map1lc3b (Mus musculus) 6480464 cupric chloride results in increased lipidation of MAP1LC3B protein CTD PMID:37981210 copper(II) chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 1 more ... CTD PMID:32512069 and PMID:37981210 copper(II) chloride increases expression ISO Map1lc3b (Mus musculus) 6480464 cupric chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:32512069 copper(II) sulfate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Copper Sulfate results in increased expression of MAP1LC3B mRNA CTD PMID:19549813 copper(II) sulfate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3B mRNA and [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3B protein CTD PMID:31491480 cordycepin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine inhibits the reaction [cordycepin results in increased expression of MAP1LC3B mRNA] CTD PMID:36299321 cordycepin affects expression ISO MAP1LC3B (Homo sapiens) 6480464 cordycepin affects the expression of MAP1LC3B mRNA CTD PMID:36881089 coumestrol decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 Coumestrol results in decreased expression of MAP1LC3B mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO Map1lc3b (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of MAP1LC3B mRNA CTD PMID:29279043 Cryptotanshinone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [cryptotanshinone results in increased expression of MAP1LC3B protein] more ... CTD PMID:28600121 Cryptotanshinone increases expression ISO MAP1LC3B (Homo sapiens) 6480464 cryptotanshinone results in increased expression of MAP1LC3B protein CTD PMID:28600121 curcumin decreases expression ISO Map1lc3b (Mus musculus) 6480464 Curcumin results in decreased expression of MAP1LC3B protein CTD PMID:36640941 curcumin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Curcumin results in increased expression of MAP1LC3B mRNA CTD PMID:34634291 curcumin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Curcumin results in increased lipidation of MAP1LC3B protein CTD PMID:34634291 curcumin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Curcumin results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:34634291 and PMID:36640941 curcumin decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 Curcumin results in decreased expression of MAP1LC3B protein CTD PMID:36640941 Curcumol multiple interactions EXP 6480464 curcumol inhibits the reaction [VEGFA protein results in increased expression of MAP1LC3B mRNA] CTD PMID:33549628 cyanamide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Cyanamide promotes the reaction [Acetaldehyde results in increased lipidation of MAP1LC3B protein] CTD PMID:24492484 cyanamide increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Cyanamide results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 cyclosporin A increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Cyclosporine results in increased expression of MAP1LC3B mRNA CTD PMID:20106945 more ... cyclosporin A multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of MAP1LC3B mRNA CTD PMID:35876585 D-glucose multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 and PMID:35243728 D-glucose decreases lipidation EXP 6480464 Glucose results in decreased lipidation of MAP1LC3B protein CTD PMID:35243728 D-glucose multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form] CTD PMID:34580807 D-glucose increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Glucose deficiency results in increased expression of MAP1LC3B protein and Glucose deficiency results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of MAP1LC3B protein CTD PMID:29128638 D-mannopyranose multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Mannose inhibits the reaction [Deoxyglucose results in increased prenylation of MAP1LC3B protein] CTD PMID:20593179 dapagliflozin multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein] CTD PMID:34939712 DDE decreases expression ISO Map1lc3b (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of MAP1LC3B mRNA CTD PMID:32721735 deguelin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 deguelin results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 Dehydroeburicoic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 calpeptin inhibits the reaction [dehydroeburicoic acid affects the localization of MAP1LC3B protein] more ... CTD PMID:19848398 Dehydroeburicoic acid affects localization ISO MAP1LC3B (Homo sapiens) 6480464 dehydroeburicoic acid affects the localization of MAP1LC3B protein CTD PMID:19848398 deoxycholic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 deoxynivalenol increases expression ISO MAP1LC3B (Homo sapiens) 6480464 deoxynivalenol results in increased expression of MAP1LC3B mRNA CTD PMID:34677630 desferrioxamine B multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Deferoxamine inhibits the reaction [di-n-propyldithiocarbamate results in increased expression of and results in increased lipidation of MAP1LC3B protein] and Iron affects the reaction [Deferoxamine results in increased expression of MAP1LC3B protein] CTD PMID:25301941 and PMID:32687844 desferrioxamine B increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Deferoxamine results in increased expression of MAP1LC3B protein CTD PMID:25301941 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of MAP1LC3B mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA] and MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA] CTD PMID:23111315 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1LC3B mRNA] CTD PMID:20032058 dexmedetomidine multiple interactions EXP 6480464 Dexmedetomidine affects the reaction [MIR330 protein affects the lipidation of MAP1LC3B protein] and Dexmedetomidine inhibits the reaction [Sevoflurane results in decreased lipidation of MAP1LC3B protein] CTD PMID:34590382 dextran sulfate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:31676321 diarsenic trioxide multiple interactions EXP 6480464 [ferrostatin-1 co-treated with Arsenic Trioxide] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29111283 and PMID:35195477 diarsenic trioxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 diarsenic trioxide increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 diarsenic trioxide increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 diarsenic trioxide multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] more ... CTD PMID:28978663 more ... diarsenic trioxide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA more ... CTD PMID:29307831 more ... diarsenic trioxide increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased cleavage of MAP1LC3B protein CTD PMID:30677399 diarsenic trioxide increases lipidation EXP 6480464 Arsenic Trioxide results in increased lipidation of MAP1LC3B protein CTD PMID:29111283 diarsenic trioxide increases expression ISO Map1lc3b (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3B mRNA and Arsenic Trioxide results in increased expression of MAP1LC3B protein CTD PMID:30032600 more ... dibenzofuran affects localization ISO MAP1LC3B (Homo sapiens) 6480464 dibenzofuran affects the localization of MAP1LC3B protein CTD PMID:22173198 dibenzofuran increases expression ISO MAP1LC3B (Homo sapiens) 6480464 dibenzofuran results in increased expression of MAP1LC3B protein modified form CTD PMID:22173198 dibutyl phthalate increases expression ISO Map1lc3b (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of MAP1LC3B mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MAP1LC3B protein CTD PMID:30053495 dibutyl phthalate increases cleavage ISO Map1lc3b (Mus musculus) 6480464 Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein CTD PMID:26804720 dibutyl phthalate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] and 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] CTD PMID:26804720 dibutyl phthalate increases cleavage EXP 6480464 Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein CTD PMID:26804720 dibutyl phthalate multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] and 4-phenylbutyric acid inhibits the reaction [Dibutyl Phthalate results in increased cleavage of MAP1LC3B protein] CTD PMID:26804720 diisononyl phthalate increases expression ISO Map1lc3b (Mus musculus) 6480464 diisononyl phthalate results in increased expression of MAP1LC3B protein CTD PMID:37976928 diisononyl phthalate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 diisononyl phthalate results in increased expression of MAP1LC3B protein CTD PMID:37976928 diisononyl phthalate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 ATF4 protein promotes the reaction [diisononyl phthalate results in increased expression of MAP1LC3B protein] and DDIT4 protein promotes the reaction [diisononyl phthalate results in increased expression of MAP1LC3B protein] CTD PMID:37976928 diosgenin multiple interactions EXP 6480464 [alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein and alpha-Chlorohydrin inhibits the reaction [Diosgenin results in decreased lipidation of MAP1LC3B protein] CTD PMID:35149085 diosgenin decreases lipidation EXP 6480464 Diosgenin results in decreased lipidation of MAP1LC3B protein CTD PMID:35149085 diosgenin decreases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Diosgenin results in decreased lipidation of MAP1LC3B protein CTD PMID:35149085 diosgenin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [[alpha-Chlorohydrin co-treated with Diosgenin] results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35149085 dioxygen multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Chloroquine co-treated with Oxygen deficiency] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:20593179 and PMID:33203845 dioxygen multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein more ... CTD PMID:35307376 dioxygen increases expression ISO Map1lc3b (Mus musculus) 6480464 Oxygen deficiency results in increased expression of MAP1LC3B mRNA CTD PMID:23624791 diquat multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Diquat co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA CTD PMID:27057282 disodium selenite multiple interactions EXP 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 disodium selenite multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 disodium selenite multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Sodium Selenite co-treated with (1 more ... CTD PMID:28757135 disulfiram multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA CTD PMID:24690739 dorsomorphin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 dorsomorphin results in increased lipidation of MAP1LC3B protein CTD PMID:31900833 dorsomorphin decreases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 dorsomorphin results in decreased lipidation of MAP1LC3B protein CTD PMID:37329965 dorsomorphin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Alpha-Amanitin inhibits the reaction [dorsomorphin results in decreased lipidation of MAP1LC3B protein] more ... CTD PMID:23680031 more ... doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with bafilomycin A1] results in increased expression of MAP1LC3B protein more ... CTD PMID:32525084 and PMID:35134463 doxorubicin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 SC-66 compound inhibits the reaction [SIRT4 protein inhibits the reaction [Doxorubicin results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:35134463 doxorubicin increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Doxorubicin results in increased lipidation of MAP1LC3B protein CTD PMID:35134463 doxorubicin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Doxorubicin results in increased expression of MAP1LC3B mRNA and Doxorubicin results in increased expression of MAP1LC3B protein CTD PMID:29803840 and PMID:37406984 doxorubicin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Doxorubicin results in increased lipidation of MAP1LC3B protein CTD PMID:26969377 doxorubicin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Doxorubicin co-treated with Resveratrol] results in increased lipidation of MAP1LC3B protein and NORAD promotes the reaction [Doxorubicin results in increased expression of MAP1LC3B protein] CTD PMID:26969377 and PMID:37406984 entinostat increases expression ISO MAP1LC3B (Homo sapiens) 6480464 entinostat results in increased expression of MAP1LC3B protein modified form CTD PMID:20962572 enzalutamide multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [enzalutamide co-treated with GSK-2816126] results in increased expression of MAP1LC3B protein modified form CTD PMID:32805266 erastin increases expression EXP 6480464 erastin results in increased expression of MAP1LC3B protein modified form CTD PMID:32937103 erastin multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [erastin results in increased expression of MAP1LC3B protein modified form] and Chloroquine promotes the reaction [erastin results in increased expression of MAP1LC3B protein modified form] CTD PMID:32937103 erlotinib hydrochloride multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Erlotinib Hydrochloride promotes the reaction [Betulinic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:30136359 ethanol increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Ethanol results in increased lipidation of MAP1LC3B protein CTD PMID:24492484 and PMID:36708882 ethanol decreases expression ISO Map1lc3b (Mus musculus) 6480464 Ethanol results in decreased expression of MAP1LC3B protein CTD PMID:34405320 ethanol decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 Ethanol results in decreased expression of MAP1LC3B protein CTD PMID:34405320 ethanol increases expression ISO Map1lc3b (Mus musculus) 6480464 Ethanol results in increased expression of MAP1LC3B mRNA and Ethanol results in increased expression of MAP1LC3B protein CTD PMID:24095927 more ... ethanol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine promotes the reaction [Ethanol results in increased expression of MAP1LC3B protein] more ... CTD PMID:24095927 and PMID:34405320 ethanol increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Ethanol results in increased expression of MAP1LC3B mRNA more ... CTD PMID:24095927 and PMID:29524503 ethanol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:24095927 more ... ethyl methanesulfonate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 everolimus multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Everolimus promotes the reaction [N-((1R and 2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl)octanamide results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:32397857 ferric ammonium citrate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein more ... CTD PMID:34826546 ferric oxide increases expression ISO Map1lc3b (Mus musculus) 6480464 ferric oxide analog results in increased expression of MAP1LC3B protein CTD PMID:24068039 ferrostatin-1 multiple interactions EXP 6480464 [ferrostatin-1 co-treated with Arsenic Trioxide] results in increased lipidation of MAP1LC3B protein CTD PMID:35195477 finasteride increases expression EXP 6480464 Finasteride results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 flavokawain B multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [flavokawain B results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:30025493 flavokawain B increases expression ISO MAP1LC3B (Homo sapiens) 6480464 flavokawain B results in increased expression of MAP1LC3B protein modified form CTD PMID:30025493 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of MAP1LC3B mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of MAP1LC3B protein CTD PMID:29606031 folic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3B mRNA CTD PMID:22206623 folic acid affects expression ISO Map1lc3b (Mus musculus) 6480464 Folic Acid affects the expression of MAP1LC3B mRNA CTD PMID:25629700 fomepizole multiple interactions ISO Map1lc3b (Mus musculus) 6480464 fomepizole inhibits the reaction [Ethanol results in increased lipidation of MAP1LC3B protein] CTD PMID:24492484 formaldehyde increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Formaldehyde results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of MAP1LC3B mRNA CTD PMID:24142868 fructose multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein] and [Dietary Fats co-treated with Fructose] results in increased lipidation of MAP1LC3B protein CTD PMID:34939712 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of MAP1LC3B mRNA CTD PMID:17785943 Garcinol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 garcinol inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3B protein] CTD PMID:36629037 gingerol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [gingerol co-treated with Hydrogen Peroxide] results in increased expression of MAP1LC3B protein modified form CTD PMID:27451028 ginsenoside Rg2 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 bafilomycin A1 promotes the reaction [ginsenoside Rg2 results in increased expression of MAP1LC3B protein modified form] CTD PMID:27305347 ginsenoside Rg2 increases expression ISO MAP1LC3B (Homo sapiens) 6480464 ginsenoside Rg2 results in increased expression of MAP1LC3B protein modified form CTD PMID:27305347 glafenine increases expression EXP 6480464 Glafenine results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 glucose multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 and PMID:35243728 glucose multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 U 0126 inhibits the reaction [Glucose deficiency results in increased expression of MAP1LC3B protein modified form] CTD PMID:34580807 glucose decreases lipidation EXP 6480464 Glucose results in decreased lipidation of MAP1LC3B protein CTD PMID:35243728 glucose increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Glucose deficiency results in increased expression of MAP1LC3B protein and Glucose deficiency results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 glucose decreases expression EXP 6480464 Glucose results in decreased expression of MAP1LC3B protein CTD PMID:29128638 glutathione multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Glutathione inhibits the reaction [Apigenin results in increased expression of MAP1LC3B protein modified form] and Glutathione inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:29247770 and PMID:34904774 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of MAP1LC3B mRNA CTD PMID:15345336 glycerol 2-phosphate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA] and MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA] CTD PMID:23111315 glycochenodeoxycholic acid decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 Glycochenodeoxycholic Acid results in decreased expression of MAP1LC3B mRNA CTD PMID:32439580 glycochenodeoxycholic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 and PMID:32439580 glycocholic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:32152650 glycyrrhizinic acid multiple interactions EXP 6480464 [Glycyrrhizic Acid co-treated with bafilomycin A1] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:32525084 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:34748272 more ... hexadecanoic acid affects localization ISO Map1lc3b (Mus musculus) 6480464 Palmitic Acid affects the localization of MAP1LC3B protein CTD PMID:30208301 hexadecanoic acid increases expression EXP 6480464 Palmitic Acid results in increased expression of MAP1LC3B protein modified form CTD PMID:32278738 hexadecanoic acid increases lipidation EXP 6480464 Palmitic Acid results in increased lipidation of MAP1LC3B protein CTD PMID:34774660 hexadecanoic acid multiple interactions EXP 6480464 C1QTNF9 protein promotes the reaction [Palmitic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32278738 hexadecanoic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of MAP1LC3B mRNA CTD PMID:30547786 hyaluronic acid multiple interactions EXP 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of MAP1LC3B protein] CTD PMID:27082295 hyaluronic acid increases cleavage EXP 6480464 Hyaluronic Acid results in increased cleavage of MAP1LC3B protein CTD PMID:27082295 hydrogen peroxide affects expression ISO MAP1LC3B (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of MAP1LC3B mRNA CTD PMID:20044591 hydrogen peroxide increases lipidation EXP 6480464 Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein CTD PMID:36639873 hydrogen peroxide multiple interactions EXP 6480464 bafilomycin A1 inhibits the reaction [olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein]] and olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein] CTD PMID:36639873 hydrogen peroxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA CTD PMID:27057282 hydrogen peroxide multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:27451028 more ... hydrogen peroxide decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of MAP1LC3B protein alternative form CTD PMID:23726866 hydrogen peroxide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Hydrogen Peroxide results in increased expression of MAP1LC3B mRNA more ... CTD PMID:23726866 and PMID:32043704 hydroquinone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 4 more ... CTD PMID:37148176 hydroquinone increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 hydroquinone results in increased lipidation of MAP1LC3B protein CTD PMID:37148176 indoxyl sulfate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of MAP1LC3B protein] CTD PMID:30849338 indoxyl sulfate increases expression ISO Map1lc3b (Mus musculus) 6480464 Indican results in increased expression of MAP1LC3B protein CTD PMID:30849338 inositol multiple interactions EXP 6480464 Inositol inhibits the reaction [Glucose results in decreased lipidation of MAP1LC3B protein] CTD PMID:35243728 iron atom multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein more ... CTD PMID:25301941 and PMID:34826546 iron(0) multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein more ... CTD PMID:25301941 and PMID:34826546 ivermectin decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 Ivermectin results in decreased expression of MAP1LC3B protein CTD PMID:32959892 ivermectin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Ivermectin results in increased expression of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:34904774 JTE-013 multiple interactions EXP 6480464 JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein] CTD PMID:37169277 juglone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] CTD PMID:20479004 kainic acid multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32057834 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of MAP1LC3B protein modified form CTD PMID:32057834 L-ascorbic acid 2-phosphate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of BMP2 mRNA] and MAP1LC3B protein affects the reaction [[Dexamethasone co-treated with ascorbate-2-phosphate co-treated with beta-glycerophosphoric acid] results in increased expression of RUNX2 mRNA] CTD PMID:23111315 L-leucine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:31676321 L-serine multiple interactions EXP 6480464 [LAMC1 protein modified form co-treated with ANGPT1 protein co-treated with Serine] inhibits the reaction [beta-N-methylamino-L-alanine results in increased expression of MAP1LC3B protein] and Serine inhibits the reaction [beta-N-methylamino-L-alanine results in increased expression of MAP1LC3B protein] CTD PMID:30476904 lactulose increases expression ISO Map1lc3b (Mus musculus) 6480464 Lactulose results in increased expression of MAP1LC3B mRNA CTD PMID:30335591 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:36652739 and PMID:36840722 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in increased expression of MAP1LC3B mRNA more ... CTD PMID:36652739 and PMID:36840722 lead(0) affects expression ISO MAP1LC3B (Homo sapiens) 6480464 Lead affects the expression of MAP1LC3B mRNA CTD PMID:28903495 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 leflunomide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 leflunomide results in increased expression of MAP1LC3B mRNA CTD PMID:28988120 levofloxacin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [TNF protein co-treated with Levofloxacin] results in increased lipidation of MAP1LC3B protein and TNF protein promotes the reaction [Levofloxacin results in increased expression of MAP1LC3B protein] CTD PMID:33609687 levofloxacin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Levofloxacin results in increased expression of MAP1LC3B protein CTD PMID:33609687 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of MAP1LC3B mRNA CTD PMID:34464015 lipopolysaccharide decreases expression ISO Map1lc3b (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of MAP1LC3B mRNA CTD PMID:35099110 lipopolysaccharide affects localization ISO Map1lc3b (Mus musculus) 6480464 Lipopolysaccharides affects the localization of MAP1LC3B protein CTD PMID:35099110 lipopolysaccharide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [stearic acid co-treated with Lipopolysaccharides] affects the expression of MAP1LC3B protein more ... CTD PMID:33810233 and PMID:35099110 luteolin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Luteolin results in increased expression of and results in increased lipidation of MAP1LC3B protein and mirdametinib inhibits the reaction [Luteolin results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:32268164 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [saikosaponin D results in decreased cleavage of MAP1LC3B protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [saikosaponin D results in increased expression of MAP1LC3B protein] CTD PMID:30611790 LY294002 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with pachastrissamine analog] results in increased lipidation of MAP1LC3B protein CTD PMID:35123989 LY294002 increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased lipidation of MAP1LC3B protein CTD PMID:35123989 LY294002 increases cleavage EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased cleavage of MAP1LC3B protein CTD PMID:30611790 manganese atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA and U 0126 inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA] CTD PMID:31690173 manganese(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA and U 0126 inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA] CTD PMID:31690173 manganese(II) chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA and U 0126 inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of MAP1LC3B mRNA] CTD PMID:31690173 melatonin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Atrazine results in increased expression of MAP1LC3B protein] more ... CTD PMID:25259610 more ... melibiose increases expression ISO Map1lc3b (Mus musculus) 6480464 Melibiose results in increased expression of MAP1LC3B mRNA CTD PMID:30335591 menadione multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein and [S 3483 co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein CTD PMID:19819344 metformin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form and Chloroquine promotes the reaction [[Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form] CTD PMID:25412314 methamphetamine multiple interactions EXP 6480464 Methamphetamine results in increased lipidation of and affects the localization of MAP1LC3B protein and STX17 protein inhibits the reaction [Methamphetamine results in increased lipidation of MAP1LC3B protein] CTD PMID:34374793 methamphetamine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 NFE2L2 protein affects the reaction [Methamphetamine results in increased expression of MAP1LC3B protein] and sulforaphane inhibits the reaction [Methamphetamine results in increased expression of MAP1LC3B protein] CTD PMID:37567421 methamphetamine increases expression ISO Map1lc3b (Mus musculus) 6480464 Methamphetamine results in increased expression of MAP1LC3B protein CTD PMID:37567421 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of MAP1LC3B mRNA CTD PMID:34374793 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 methotrexate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Methotrexate results in increased expression of MAP1LC3B mRNA CTD PMID:21678067 methyl methanesulfonate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 methylisothiazolinone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of and results in increased cleavage of MAP1LC3B protein CTD PMID:29110394 methylisothiazolinone increases expression ISO MAP1LC3B (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of MAP1LC3B protein CTD PMID:31629900 methylmercury chloride increases expression ISO Map1lc3b (Mus musculus) 6480464 methylmercuric chloride results in increased expression of MAP1LC3B protein modified form CTD PMID:27667695 methylmercury chloride increases expression ISO MAP1LC3B (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of MAP1LC3B mRNA more ... CTD PMID:27667695 more ... methylmercury chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG5 promotes the reaction [methylmercuric chloride results in increased cleavage of MAP1LC3B protein] and U 0126 inhibits the reaction [methylmercuric chloride results in increased expression of MAP1LC3B protein modified form] CTD PMID:27667695 methylmercury chloride increases cleavage ISO Map1lc3b (Mus musculus) 6480464 methylmercuric chloride results in increased cleavage of MAP1LC3B protein CTD PMID:27667695 methylphenidate decreases expression ISO Map1lc3b (Mus musculus) 6480464 Methylphenidate results in decreased expression of MAP1LC3B mRNA CTD PMID:22470460 methylphenidate increases expression EXP 6480464 Methylphenidate results in increased expression of MAP1LC3B mRNA CTD PMID:32746681 metyrapone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Metyrapone co-treated with Vitamin K 3] results in increased expression of MAP1LC3B protein CTD PMID:19819344 miconazole increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Miconazole results in increased lipidation of MAP1LC3B protein CTD PMID:32981224 miconazole multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [bafilomycin A1 co-treated with Miconazole] results in increased expression of MAP1LC3B protein and bafilomycin A1 promotes the reaction [Miconazole results in increased lipidation of MAP1LC3B protein] CTD PMID:32981224 mitoxantrone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Mitoxantrone results in decreased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:36216988 MJN110 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 MJN110 affects the reaction [Chloroquine results in increased lipidation of MAP1LC3B protein] CTD PMID:30301768 MJN110 increases lipidation ISO Map1lc3b (Mus musculus) 6480464 MJN110 results in increased lipidation of MAP1LC3B protein CTD PMID:30301768 MK-2206 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 MK 2206 promotes the reaction [butein results in increased lipidation of MAP1LC3B protein] CTD PMID:35130734 mono(2-ethylhexyl) phthalate multiple interactions ISO Map1lc3b (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased localization of MAP1LC3B protein CTD PMID:37692514 myriocin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 thermozymocidin inhibits the reaction [Dronabinol results in increased expression of and affects the localization of and affects the lipidation of MAP1LC3B protein] CTD PMID:27635674 N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [N-(1 more ... CTD PMID:29128638 N-acetyl-L-cysteine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased metabolism of MAP1LC3B protein] more ... CTD PMID:20543569 more ... N-acetyl-L-cysteine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Acetylcysteine results in increased expression of MAP1LC3B protein and Acetylcysteine results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 N-acetyl-L-cysteine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [[Aluminum Chloride results in increased abundance of Aluminum] which results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:30849338 more ... N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [cadmium acetate affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein]] more ... CTD PMID:27832966 and PMID:28347754 N-acylsphinganine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 dihydroceramide analog results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32397857 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO MAP1LC3B (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of MAP1LC3B protein modified form CTD PMID:26409479 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [trovafloxacin results in increased expression of and results in increased lipidation of MAP1LC3B protein] and MAP1LC3B protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased phosphorylation of NFKBIA protein] CTD PMID:24085292 and PMID:33609687 N-methyl-4-phenylpyridinium decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3B protein CTD PMID:36629037 N-methyl-4-phenylpyridinium multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of and results in increased lipidation of MAP1LC3B protein more ... CTD PMID:36078115 more ... NADP zwitterion multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32057834 NADP(+) multiple interactions EXP 6480464 NADP inhibits the reaction [Kainic Acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:32057834 Naftopidil affects expression ISO MAP1LC3B (Homo sapiens) 6480464 naftopidil affects the expression of MAP1LC3B protein CTD PMID:29374705 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 nefazodone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in increased expression of MAP1LC3B mRNA and nefazodone results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32152650 and PMID:33609687 nefazodone increases expression ISO MAP1LC3B (Homo sapiens) 6480464 nefazodone results in increased expression of MAP1LC3B mRNA CTD PMID:32152650 nelfinavir increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Nelfinavir results in increased expression of MAP1LC3B protein CTD PMID:20594311 nelfinavir multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Tamoxifen promotes the reaction [Nelfinavir results in increased expression of MAP1LC3B protein] CTD PMID:20594311 nickel dichloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [nickel chloride results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:36421005 nickel dichloride increases expression ISO Map1lc3b (Mus musculus) 6480464 nickel chloride results in increased expression of MAP1LC3B mRNA CTD PMID:36421005 niclosamide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Niclosamide results in increased expression of MAP1LC3B protein modified form CTD PMID:30258081 nicotinamide multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Niacinamide inhibits the reaction [[TNF protein co-treated with resveratrol] results in increased expression of MAP1LC3B protein alternative form] CTD PMID:24145604 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of MAP1LC3B mRNA CTD PMID:24136188 Nivalenol decreases expression ISO Map1lc3b (Mus musculus) 6480464 nivalenol results in decreased expression of MAP1LC3B mRNA CTD PMID:35016910 Nonylphenol increases cleavage EXP 6480464 nonylphenol results in increased cleavage of MAP1LC3B protein CTD PMID:27832966 Nonylphenol affects expression EXP 6480464 nonylphenol affects the expression of MAP1LC3B protein CTD PMID:27832966 Nonylphenol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [nonylphenol results in increased expression of MAP1LC3B protein] CTD PMID:27832966 obeticholic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 obeticholic acid inhibits the reaction [Dietary Fats results in decreased expression of MAP1LC3B protein] CTD PMID:26655953 ochratoxin A multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 4-phenylbutyric acid inhibits the reaction [ochratoxin A results in increased expression of MAP1LC3B protein] CTD PMID:36058351 ochratoxin A increases expression ISO MAP1LC3B (Homo sapiens) 6480464 ochratoxin A results in increased expression of MAP1LC3B protein CTD PMID:36058351 octadecanoic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [stearic acid co-treated with Lipopolysaccharides] affects the expression of MAP1LC3B protein CTD PMID:33810233 octreotide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Octreotide inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in decreased expression of MAP1LC3B protein] more ... CTD PMID:35307376 olaparib multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine promotes the reaction [olaparib promotes the reaction [[ferric ammonium citrate results in increased abundance of Iron] which results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:34826546 olaparib multiple interactions EXP 6480464 bafilomycin A1 inhibits the reaction [olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein]] and olaparib inhibits the reaction [Hydrogen Peroxide results in increased lipidation of MAP1LC3B protein] CTD PMID:36639873 oleanolic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Cisplatin promotes the reaction [Oleanolic Acid results in increased expression of MAP1LC3B protein] more ... CTD PMID:31306688 and PMID:35690101 oleanolic acid increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Oleanolic Acid results in increased expression of MAP1LC3B protein CTD PMID:31306688 oleanolic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Oleanolic Acid inhibits the reaction [Cisplatin results in increased expression of MAP1LC3B protein] CTD PMID:31306688 oleic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of MAP1LC3B mRNA CTD PMID:30547786 Ophiopogonin D multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-(2 and 4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [ophiopogonin D results in increased expression of MAP1LC3B protein] CTD PMID:35905946 Ophiopogonin D increases expression ISO MAP1LC3B (Homo sapiens) 6480464 ophiopogonin D results in increased expression of MAP1LC3B protein CTD PMID:35905946 oxidopamine increases expression EXP 6480464 Oxidopamine results in increased expression of MAP1LC3B protein modified form CTD PMID:28802652 ozone increases expression ISO Map1lc3b (Mus musculus) 6480464 Ozone results in increased expression of MAP1LC3B protein CTD PMID:35866636 paclitaxel increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Paclitaxel results in increased expression of MAP1LC3B mRNA and Paclitaxel results in increased expression of MAP1LC3B protein CTD PMID:19815708 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of MAP1LC3B mRNA CTD PMID:35921949 paclitaxel multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAP1LC3B mRNA] CTD PMID:35921949 paracetamol increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Acetaminophen results in increased expression of MAP1LC3B mRNA CTD PMID:21420995 and PMID:29067470 paracetamol increases expression ISO Map1lc3b (Mus musculus) 6480464 Acetaminophen results in increased expression of MAP1LC3B mRNA CTD PMID:37179516 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAP1LC3B protein CTD PMID:28682524 paracetamol multiple interactions EXP 6480464 chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein] CTD PMID:28682524 paraformaldehyde macromolecule multiple interactions ISO Map1lc3b (Mus musculus) 6480464 GDF11 protein promotes the reaction [sodium bisulfide inhibits the reaction [paraform results in increased expression of MAP1LC3B protein]] and sodium bisulfide inhibits the reaction [paraform results in increased expression of MAP1LC3B protein] CTD PMID:37105376 paraformaldehyde macromolecule increases expression ISO Map1lc3b (Mus musculus) 6480464 paraform results in increased expression of MAP1LC3B protein CTD PMID:37105376 paraquat multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [ST2825 co-treated with Paraquat] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:27246695 more ... paraquat increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Paraquat results in increased expression of MAP1LC3B mRNA CTD PMID:27220436 paraquat multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Paraquat inhibits the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] CTD PMID:26409479 paraquat increases expression ISO Map1lc3b (Mus musculus) 6480464 Paraquat results in increased expression of MAP1LC3B protein CTD PMID:25092649 more ... parthenolide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 parthenolide inhibits the reaction [[Air Pollutants results in increased abundance of Particulate Matter] which results in increased expression of MAP1LC3B protein] CTD PMID:37858773 PD 0325901 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 mirdametinib inhibits the reaction [Luteolin results in increased expression of and results in increased lipidation of MAP1LC3B protein] CTD PMID:32268164 pectolinarigenin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine promotes the reaction [pectolinarigenin results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:37393350 pectolinarigenin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 pectolinarigenin results in increased lipidation of MAP1LC3B protein CTD PMID:37393350 Pentoxifylline multiple interactions EXP 6480464 Pentoxifylline inhibits the reaction [Cisplatin results in decreased expression of MAP1LC3B protein modified form] CTD PMID:32777238 pepstatin A multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:21184746 more ... pepstatin A multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [aloxistatin co-treated with pepstatin] inhibits the reaction [Biological Factors deficiency results in increased degradation of MAP1LC3B protein modified form] more ... CTD PMID:26483381 and PMID:27635674 perfluorobutyric acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [perfluorooctanoic acid co-treated with perfluorobutyric acid co-treated with perfluorotetradecanoic acid] results in increased expression of MAP1LC3B protein CTD PMID:37806615 perfluorooctane-1-sulfonic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of MAP1LC3B protein modified form CTD PMID:32861759 perfluorooctane-1-sulfonic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of MAP1LC3B mRNA CTD PMID:36331819 perfluorooctanoic acid multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [perfluorooctanoic acid co-treated with perfluorobutyric acid co-treated with perfluorotetradecanoic acid] results in increased expression of MAP1LC3B protein and ATG5 protein promotes the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form] CTD PMID:26879310 and PMID:37806615 perfluorooctanoic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3B mRNA and perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form CTD PMID:26879310 perfluorooctanoic acid increases expression ISO MAP1LC3B (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3B mRNA and perfluorooctanoic acid results in increased expression of MAP1LC3B protein modified form CTD PMID:26879310 and PMID:37806615 perfluoroundecanoic acid increases expression EXP 6480464 perfluoroundecanoic acid results in increased expression of MAP1LC3B protein CTD PMID:33549592 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of MAP1LC3B mRNA CTD PMID:19162173 phenobarbital affects expression ISO MAP1LC3B (Homo sapiens) 6480464 Phenobarbital affects the expression of MAP1LC3B mRNA CTD PMID:19159669 phorbol 13-acetate 12-myristate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] more ... CTD PMID:20479004 phorbol 13-acetate 12-myristate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein CTD PMID:20479004 phosphatidylethanolamine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 calpeptin inhibits the reaction [dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine]] and dehydroeburicoic acid promotes the reaction [MAP1LC3B protein binds to phosphatidylethanolamine] CTD PMID:19848398 pirinixic acid multiple interactions ISO Map1lc3b (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP1LC3B mRNA] CTD PMID:21318169 pirinixic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 pirinixic acid results in increased expression of MAP1LC3B mRNA CTD PMID:18301758 more ... platycodin D increases expression ISO MAP1LC3B (Homo sapiens) 6480464 platycodin D results in increased expression of MAP1LC3B mRNA and platycodin D results in increased expression of MAP1LC3B protein CTD PMID:26078792 potassium chromate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of MAP1LC3B mRNA CTD PMID:22079256 potassium chromate increases expression ISO MAP1LC3B (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of MAP1LC3B mRNA CTD PMID:22079256 and PMID:22714537 potassium dichromate multiple interactions EXP 6480464 Potassium Dichromate results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:36416502 pregnenolone 16alpha-carbonitrile increases expression ISO Map1lc3b (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of MAP1LC3B mRNA CTD PMID:28903501 procyanidin B2 multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [Diquat co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA and [Hydrogen Peroxide co-treated with procyanidin B2] results in increased expression of MAP1LC3B mRNA CTD PMID:27057282 pterostilbene multiple interactions ISO Map1lc3b (Mus musculus) 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]] CTD PMID:34405320 pterostilbene multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein] and SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]] CTD PMID:34405320 puerarin multiple interactions EXP 6480464 puerarin inhibits the reaction [cadmium acetate results in decreased expression of MAP1LC3B protein modified form] CTD PMID:34897960 quercetin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Quercetin results in increased expression of MAP1LC3B mRNA and Quercetin results in increased expression of MAP1LC3B protein CTD PMID:21632981 and PMID:28251795 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in increased expression of MAP1LC3B mRNA] more ... CTD PMID:32347499 more ... quercetin increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 Quercetin results in increased cleavage of MAP1LC3B protein CTD PMID:28251795 quercetin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Quercetin results in increased cleavage of MAP1LC3B protein] and benzyloxycarbonyl-valyl-alanyl-aspartyl-fluoromethane inhibits the reaction [Quercetin results in increased cleavage of MAP1LC3B protein] CTD PMID:28251795 quetiapine fumarate decreases metabolic processing ISO Map1lc3b (Mus musculus) 6480464 Quetiapine Fumarate results in decreased metabolism of MAP1LC3B protein CTD PMID:31220554 rac-1-monopalmitoylglycerol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Chloroquine promotes the reaction [palmitoyl glycerol results in increased lipidation of MAP1LC3B protein] CTD PMID:37466199 rac-1-monopalmitoylglycerol increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 palmitoyl glycerol results in increased lipidation of MAP1LC3B protein CTD PMID:37466199 radon atom multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Radon results in increased expression of MAP1LC3B protein] CTD PMID:33107683 radon atom increases expression ISO Map1lc3b (Mus musculus) 6480464 Radon results in increased expression of MAP1LC3B protein CTD PMID:33107683 radon(0) increases expression ISO Map1lc3b (Mus musculus) 6480464 Radon results in increased expression of MAP1LC3B protein CTD PMID:33107683 radon(0) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Melatonin inhibits the reaction [Radon results in increased expression of MAP1LC3B protein] CTD PMID:33107683 raloxifene increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Raloxifene Hydrochloride results in increased lipidation of MAP1LC3B protein CTD PMID:33203845 raloxifene multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with Oxygen deficiency] results in increased lipidation of MAP1LC3B protein CTD PMID:33203845 resveratrol affects metabolic processing ISO MAP1LC3B (Homo sapiens) 6480464 resveratrol affects the metabolism of MAP1LC3B protein CTD PMID:23680031 resveratrol increases lipidation EXP 6480464 Resveratrol results in increased lipidation of MAP1LC3B protein CTD PMID:32619457 resveratrol increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 resveratrol results in increased lipidation of MAP1LC3B protein CTD PMID:26969377 resveratrol multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with Resveratrol] promotes the reaction [MAP1LC3B protein binds to TOMM20 protein] more ... CTD PMID:32619457 resveratrol increases expression ISO Map1lc3b (Mus musculus) 6480464 resveratrol results in increased expression of MAP1LC3B mRNA CTD PMID:24095927 resveratrol multiple interactions ISO Map1lc3b (Mus musculus) 6480464 resveratrol promotes the reaction [Ethanol results in increased expression of MAP1LC3B mRNA] CTD PMID:24095927 resveratrol multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [[TNF protein co-treated with Resveratrol] results in increased expression of MAP1LC3B protein alternative form] more ... CTD PMID:23680031 more ... resveratrol increases expression ISO MAP1LC3B (Homo sapiens) 6480464 resveratrol results in increased expression of MAP1LC3B mRNA and resveratrol results in increased expression of MAP1LC3B protein alternative form CTD PMID:23750556 and PMID:24145604 rifampicin decreases metabolic processing ISO MAP1LC3B (Homo sapiens) 6480464 Rifampin results in decreased metabolism of MAP1LC3B protein CTD PMID:29908302 rifampicin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Rifampin results in increased lipidation of MAP1LC3B protein CTD PMID:31648047 rifampicin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 ATP6V0D1 protein affects the reaction [Rifampin inhibits the reaction [Rotenone results in increased lipidation of MAP1LC3B protein]] more ... CTD PMID:31648047 rimonabant multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Rimonabant results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:31570772 rotenone decreases expression ISO Map1lc3b (Mus musculus) 6480464 Rotenone results in decreased expression of MAP1LC3B mRNA CTD PMID:23186747 rotenone decreases lipidation EXP 6480464 Rotenone results in decreased lipidation of MAP1LC3B protein CTD PMID:35104487 rotenone multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]] and Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein] CTD PMID:35104487 rotenone multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 4 more ... CTD PMID:30673822 more ... rotenone increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Rotenone results in increased lipidation of MAP1LC3B protein CTD PMID:31648047 and PMID:37156403 rotenone increases expression EXP 6480464 Rotenone results in increased expression of MAP1LC3B mRNA CTD PMID:28374803 rotenone multiple interactions ISO Map1lc3b (Mus musculus) 6480464 wortmannin inhibits the reaction [Rotenone results in increased expression of MAP1LC3B protein] CTD PMID:26847702 rotenone increases expression ISO Map1lc3b (Mus musculus) 6480464 Rotenone results in increased expression of MAP1LC3B protein CTD PMID:26847702 roxadustat multiple interactions EXP 6480464 roxadustat promotes the reaction [Hyaluronic Acid results in increased cleavage of MAP1LC3B protein] CTD PMID:27082295 ruthenium red multiple interactions EXP 6480464 Ruthenium Red inhibits the reaction [Cadmium Compounds results in increased lipidation of MAP1LC3B protein] CTD PMID:34308505 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Buthionine Sulfoximine promotes the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein] and Cadmium Chloride promotes the reaction [Buthionine Sulfoximine results in increased expression of MAP1LC3B protein] CTD PMID:34580807 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Buthionine Sulfoximine results in increased expression of MAP1LC3B protein and Buthionine Sulfoximine results in increased expression of MAP1LC3B protein modified form CTD PMID:34580807 SCH772984 multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 SCH772984 inhibits the reaction [pachastrissamine analog results in increased lipidation of MAP1LC3B protein] CTD PMID:35123989 sepantronium increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 sepantronium results in increased lipidation of MAP1LC3B protein CTD PMID:31837377 sepantronium multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [sepantronium results in increased lipidation of MAP1LC3B protein] and Chloroquine promotes the reaction [sepantronium results in increased lipidation of MAP1LC3B protein] CTD PMID:31837377 serpentine asbestos increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Asbestos and Serpentine results in increased expression of MAP1LC3B mRNA CTD PMID:24735948 sertraline increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Sertraline results in increased lipidation of MAP1LC3B protein CTD PMID:33124469 sertraline multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 dorsomorphin inhibits the reaction [Sertraline results in increased lipidation of MAP1LC3B protein] CTD PMID:33124469 sevoflurane decreases lipidation EXP 6480464 Sevoflurane results in decreased lipidation of MAP1LC3B protein CTD PMID:34590382 sevoflurane increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Sevoflurane results in increased lipidation of MAP1LC3B protein CTD PMID:35472370 sevoflurane multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Sevoflurane results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:35472370 sevoflurane decreases expression ISO Map1lc3b (Mus musculus) 6480464 Sevoflurane results in decreased expression of MAP1LC3B protein CTD PMID:35249202 sevoflurane multiple interactions EXP 6480464 Dexmedetomidine inhibits the reaction [Sevoflurane results in decreased lipidation of MAP1LC3B protein] more ... CTD PMID:34590382 and PMID:36177783 silicon dioxide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of MAP1LC3B mRNA and Silicon Dioxide analog results in increased expression of MAP1LC3B protein CTD PMID:23806026 and PMID:25895662 silicon dioxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 GAS6 gene mutant form inhibits the reaction [Silicon Dioxide results in increased expression of MAP1LC3B protein modified form] and MERTK gene mutant form inhibits the reaction [Silicon Dioxide results in increased expression of MAP1LC3B protein modified form] CTD PMID:33232774 silicon dioxide increases expression ISO Map1lc3b (Mus musculus) 6480464 Silicon Dioxide analog results in increased expression of MAP1LC3B protein alternative form more ... CTD PMID:19073995 more ... silver atom increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Silver results in increased expression of MAP1LC3B mRNA and Silver results in increased expression of MAP1LC3B protein modified form CTD PMID:26014281 and PMID:28987793 silver(0) increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Silver results in increased expression of MAP1LC3B mRNA and Silver results in increased expression of MAP1LC3B protein modified form CTD PMID:26014281 and PMID:28987793 simvastatin increases expression ISO Map1lc3b (Mus musculus) 6480464 Simvastatin results in increased expression of MAP1LC3B protein CTD PMID:23817226 simvastatin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form and Chloroquine promotes the reaction [[Simvastatin co-treated with Metformin] results in increased expression of MAP1LC3B protein modified form] CTD PMID:25412314 sirolimus increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Sirolimus results in increased expression of MAP1LC3B mRNA more ... CTD PMID:19815708 more ... sirolimus increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Sirolimus results in increased lipidation of MAP1LC3B protein CTD PMID:34281243 more ... sirolimus increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Sirolimus results in increased lipidation of MAP1LC3B protein CTD PMID:29793971 sirolimus multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [bisphenol A co-treated with Sirolimus] results in increased lipidation of MAP1LC3B protein more ... CTD PMID:29518472 more ... sirolimus multiple interactions ISO Map1lc3b (Mus musculus) 6480464 CD38 gene mutant form promotes the reaction [Sirolimus results in increased expression of MAP1LC3B protein] more ... CTD PMID:24445604 more ... sirolimus affects metabolic processing ISO MAP1LC3B (Homo sapiens) 6480464 Sirolimus affects the metabolism of MAP1LC3B protein CTD PMID:23680031 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of MAP1LC3B mRNA and Sirolimus results in increased expression of MAP1LC3B protein modified form CTD PMID:18640276 and PMID:30611790 sirolimus multiple interactions EXP 6480464 3-methyladenine inhibits the reaction [Sirolimus results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:18640276 more ... sirolimus affects localization EXP 6480464 Sirolimus affects the localization of MAP1LC3B protein CTD PMID:18640276 sirolimus increases expression ISO Map1lc3b (Mus musculus) 6480464 Sirolimus results in increased expression of MAP1LC3B mRNA more ... CTD PMID:21681844 more ... sodium arsenate multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:32525701 sodium arsenite increases expression ISO MAP1LC3B (Homo sapiens) 6480464 sodium arsenite results in increased expression of MAP1LC3B protein CTD PMID:19577553 more ... sodium arsenite multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG7 gene mutant form inhibits the reaction [sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein] and sodium arsenite results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:26483381 sodium arsenite multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of MAP1LC3B mRNA CTD PMID:31844926 sodium arsenite decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MAP1LC3B mRNA CTD PMID:28595984 and PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of MAP1LC3B protein CTD PMID:26432159 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MAP1LC3B mRNA CTD PMID:19072884 sodium arsenite increases expression ISO Map1lc3b (Mus musculus) 6480464 sodium arsenite results in increased expression of MAP1LC3B protein CTD PMID:27413109 sodium arsenite multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Decitabine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3B protein] more ... CTD PMID:19577553 and PMID:27107786 sodium fluoride increases expression ISO Map1lc3b (Mus musculus) 6480464 Sodium Fluoride results in increased expression of MAP1LC3B mRNA CTD PMID:29505816 more ... sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of MAP1LC3B protein CTD PMID:35413380 sodium fluoride multiple interactions EXP 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [Sodium Fluoride results in increased abundance of Fluorides]] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:31844926 and PMID:35413380 sodium fluoride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 TGFB1 protein promotes the reaction [Sodium Fluoride results in increased expression of MAP1LC3B mRNA] CTD PMID:29505816 Soman increases expression EXP 6480464 Soman results in increased expression of MAP1LC3B mRNA CTD PMID:19281266 sphingosine 1-phosphate increases expression EXP 6480464 sphingosine 1-phosphate results in increased expression of MAP1LC3B mRNA CTD PMID:37169277 sphingosine 1-phosphate multiple interactions EXP 6480464 JTE 013 inhibits the reaction [sphingosine 1-phosphate results in increased phosphorylation of and results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:37169277 spironolactone increases expression EXP 6480464 Spironolactone results in increased expression of MAP1LC3B protein CTD PMID:30734886 streptozocin multiple interactions EXP 6480464 [[Streptozocin co-treated with Carbamazepine] affects the susceptibility to Dietary Fats] which results in decreased expression of MAP1LC3B mRNA CTD PMID:35786680 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of MAP1LC3B mRNA CTD PMID:30047161 sulforaphane increases expression ISO MAP1LC3B (Homo sapiens) 6480464 sulforaphane results in increased expression of MAP1LC3B mRNA CTD PMID:32111854 sulforaphane multiple interactions ISO Map1lc3b (Mus musculus) 6480464 sulforaphane inhibits the reaction [Methamphetamine results in increased expression of MAP1LC3B protein] CTD PMID:37567421 sulfur dioxide multiple interactions EXP 6480464 Sulfur Dioxide inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased lipidation of MAP1LC3B protein] CTD PMID:30503585 swainsonine increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Swainsonine results in increased lipidation of MAP1LC3B protein CTD PMID:36402259 swainsonine multiple interactions EXP 6480464 Swainsonine results in increased localization of and results in increased lipidation of MAP1LC3B protein CTD PMID:37442287 swainsonine increases expression ISO Map1lc3b (Mus musculus) 6480464 Swainsonine results in increased expression of MAP1LC3B mRNA CTD PMID:36402259 swainsonine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 [bafilomycin A1 co-treated with Swainsonine] results in increased expression of MAP1LC3B mRNA and [bafilomycin A1 co-treated with Swainsonine] results in increased lipidation of MAP1LC3B protein CTD PMID:36402259 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of MAP1LC3B mRNA CTD PMID:29413859 T-2 toxin affects expression ISO Map1lc3b (Mus musculus) 6480464 T-2 Toxin affects the expression of MAP1LC3B protein CTD PMID:36402210 T-2 toxin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 3-methyladenine affects the reaction [T-2 Toxin affects the expression of MAP1LC3B protein] CTD PMID:36402210 T-2 toxin multiple interactions EXP 6480464 T-2 Toxin results in increased expression of and results in increased cleavage of MAP1LC3B protein CTD PMID:29413859 tamoxifen decreases response to substance ISO MAP1LC3B (Homo sapiens) 6480464 MAP1LC3B protein results in decreased susceptibility to Tamoxifen CTD PMID:20479004 tamoxifen increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Tamoxifen results in increased expression of MAP1LC3B protein CTD PMID:25301941 tamoxifen affects expression ISO Map1lc3b (Mus musculus) 6480464 Tamoxifen affects the expression of MAP1LC3B mRNA CTD PMID:17555576 tamoxifen multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Tamoxifen promotes the reaction [Nelfinavir results in increased expression of MAP1LC3B protein] CTD PMID:20594311 taurine multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 taurine multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Taurine inhibits the reaction [Arsenic Trioxide results in increased cleavage of MAP1LC3B protein] and Taurine inhibits the reaction [Arsenic Trioxide results in increased expression of MAP1LC3B protein] CTD PMID:30237538 and PMID:30677399 taurocholic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Taurocholic Acid results in increased expression of MAP1LC3B protein CTD PMID:24189133 tebufenpyrad increases expression ISO MAP1LC3B (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 temozolomide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 temozolomide results in increased expression of MAP1LC3B protein CTD PMID:19567134 temozolomide multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein] CTD PMID:19567134 tert-butyl hydroperoxide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 tert-Butylhydroperoxide results in increased expression of MAP1LC3B mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of MAP1LC3B mRNA] CTD PMID:20032058 tetrachloromethane affects expression ISO Map1lc3b (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of MAP1LC3B mRNA CTD PMID:17484886 tetrachloromethane increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Carbon Tetrachloride results in increased lipidation of MAP1LC3B protein CTD PMID:35405287 tetrachloromethane multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Sirolimus inhibits the reaction [Carbon Tetrachloride results in increased lipidation of MAP1LC3B protein] CTD PMID:35405287 thalidomide multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Thalidomide promotes the reaction [temozolomide results in increased expression of MAP1LC3B protein] CTD PMID:19567134 thapsigargin multiple interactions EXP 6480464 Thapsigargin affects the localization of [LAMP1 protein co-treated with MAP1LC3B protein] more ... CTD PMID:28347754 thapsigargin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Thapsigargin promotes the reaction [Cadmium Chloride results in increased expression of MAP1LC3B protein modified form] CTD PMID:25639782 thiamine(1+) chloride multiple interactions EXP 6480464 Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 thiamine(1+) chloride multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form] CTD PMID:31419397 thifluzamide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 thifluzamide results in increased expression of MAP1LC3B mRNA CTD PMID:33512557 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of MAP1LC3B mRNA CTD PMID:34492290 titanium dioxide increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 titanium dioxide results in increased lipidation of MAP1LC3B protein CTD PMID:31927068 titanium dioxide increases expression ISO Map1lc3b (Mus musculus) 6480464 titanium dioxide analog results in increased expression of MAP1LC3B protein and titanium dioxide results in increased expression of MAP1LC3B mRNA CTD PMID:25111187 and PMID:29792337 toosendanin increases lipidation ISO MAP1LC3B (Homo sapiens) 6480464 toosendanin analog results in increased lipidation of MAP1LC3B protein and toosendanin results in increased lipidation of MAP1LC3B protein CTD PMID:34742683 trametinib multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 trametinib affects the expression of and affects the lipidation of MAP1LC3B protein CTD PMID:30339727 tricalcium bis(phosphate) multiple interactions ISO Map1lc3b (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [tricalcium phosphate affects the localization of MAP1LC3B protein] and bafilomycin A1 promotes the reaction [tricalcium phosphate results in increased expression of MAP1LC3B protein] CTD PMID:37678662 tricalcium bis(phosphate) affects localization ISO Map1lc3b (Mus musculus) 6480464 tricalcium phosphate affects the localization of MAP1LC3B protein CTD PMID:37678662 trichostatin A affects localization ISO MAP1LC3B (Homo sapiens) 6480464 trichostatin A affects the localization of MAP1LC3B protein modified form CTD PMID:20543569 trichostatin A multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG7 gene mutant form inhibits the reaction [trichostatin A promotes the reaction [Cisplatin results in increased expression of MAP1LC3B protein modified form]] more ... CTD PMID:29476062 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 trichostatin A multiple interactions EXP 6480464 Chloroquine promotes the reaction [trichostatin A results in increased expression of MAP1LC3B protein modified form] CTD PMID:29476062 trichostatin A increases expression ISO Map1lc3b (Mus musculus) 6480464 trichostatin A results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 trichostatin A affects expression ISO MAP1LC3B (Homo sapiens) 6480464 trichostatin A affects the expression of MAP1LC3B mRNA CTD PMID:28542535 trichostatin A increases expression ISO MAP1LC3B (Homo sapiens) 6480464 trichostatin A results in increased expression of MAP1LC3B mRNA and trichostatin A results in increased expression of MAP1LC3B protein modified form CTD PMID:19606018 and PMID:20962572 trichostatin A increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 trichostatin A results in increased cleavage of MAP1LC3B protein CTD PMID:20543569 triclosan decreases expression ISO MAP1LC3B (Homo sapiens) 6480464 Triclosan results in decreased expression of MAP1LC3B mRNA CTD PMID:34681664 trifloxystrobin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 trifloxystrobin results in increased expression of MAP1LC3B protein alternative form CTD PMID:27853101 trimethyltin decreases degradation EXP 6480464 trimethyltin results in decreased degradation of MAP1LC3B protein modified form CTD PMID:26459185 Triptolide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 triptolide results in increased expression of MAP1LC3B protein CTD PMID:31218727 trovafloxacin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [trovafloxacin co-treated with TNF protein] results in increased expression of MAP1LC3B mRNA more ... CTD PMID:33609687 trovafloxacin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 trovafloxacin results in increased expression of MAP1LC3B mRNA CTD PMID:33609687 tunicamycin increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Tunicamycin results in increased expression of MAP1LC3B protein and Tunicamycin results in increased expression of MAP1LC3B protein modified form CTD PMID:20962572 and PMID:36640941 tunicamycin multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 Curcumin inhibits the reaction [Tunicamycin results in increased expression of MAP1LC3B protein] CTD PMID:36640941 tunicamycin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 ATG5 protein mutant form inhibits the reaction [Tunicamycin results in increased lipidation of MAP1LC3B protein] more ... CTD PMID:29793971 tunicamycin increases lipidation ISO Map1lc3b (Mus musculus) 6480464 Tunicamycin results in increased lipidation of MAP1LC3B protein CTD PMID:29793971 tunicamycin increases prenylation ISO MAP1LC3B (Homo sapiens) 6480464 Tunicamycin results in increased prenylation of MAP1LC3B protein CTD PMID:20593179 urethane increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Urethane results in increased expression of MAP1LC3B mRNA CTD PMID:28818685 valproic acid affects expression ISO Map1lc3b (Mus musculus) 6480464 Valproic Acid affects the expression of MAP1LC3B mRNA CTD PMID:17292431 and PMID:17963808 valproic acid affects expression ISO MAP1LC3B (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP1LC3B mRNA CTD PMID:25979313 valproic acid increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Valproic Acid results in increased expression of MAP1LC3B mRNA CTD PMID:22083351 more ... valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MAP1LC3B mRNA CTD PMID:21318169 valproic acid increases expression ISO Map1lc3b (Mus musculus) 6480464 Valproic Acid results in increased expression of MAP1LC3B mRNA CTD PMID:20546886 and PMID:21427059 venlafaxine hydrochloride multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein]] and Venlafaxine Hydrochloride inhibits the reaction [Rotenone results in decreased lipidation of MAP1LC3B protein] CTD PMID:35104487 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of MAP1LC3B gene CTD PMID:31682807 vincristine increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Vincristine results in increased expression of MAP1LC3B mRNA CTD PMID:23649840 vincristine multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in increased expression of MAP1LC3B protein] CTD PMID:36808657 vincristine increases expression EXP 6480464 Vincristine results in increased expression of MAP1LC3B protein CTD PMID:36808657 vismodegib multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 HhAntag691 inhibits the reaction [nickel monoxide results in decreased lipidation of and results in decreased cleavage of MAP1LC3B protein] CTD PMID:34608745 vorinostat affects localization ISO MAP1LC3B (Homo sapiens) 6480464 vorinostat affects the localization of MAP1LC3B protein modified form CTD PMID:20543569 vorinostat multiple interactions EXP 6480464 Chloroquine promotes the reaction [Vorinostat results in increased expression of MAP1LC3B protein modified form] CTD PMID:29476062 vorinostat increases expression EXP 6480464 Vorinostat results in increased expression of MAP1LC3B protein modified form CTD PMID:29476062 vorinostat increases expression ISO MAP1LC3B (Homo sapiens) 6480464 vorinostat results in increased expression of MAP1LC3B mRNA and vorinostat results in increased expression of MAP1LC3B protein modified form CTD PMID:20962572 and PMID:22083351 vorinostat increases cleavage ISO MAP1LC3B (Homo sapiens) 6480464 vorinostat results in increased cleavage of MAP1LC3B protein CTD PMID:17881280 and PMID:20543569 vorinostat multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [vorinostat results in increased expression of MAP1LC3B protein modified form] more ... CTD PMID:17881280 more ... wortmannin decreases expression ISO Map1lc3b (Mus musculus) 6480464 wortmannin results in decreased expression of MAP1LC3B protein CTD PMID:26847702 wortmannin multiple interactions ISO Map1lc3b (Mus musculus) 6480464 wortmannin inhibits the reaction [Rotenone results in increased expression of MAP1LC3B protein] CTD PMID:26847702 zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of MAP1LC3B protein CTD PMID:31586597 and PMID:32858132 zearalenone increases expression ISO Map1lc3b (Mus musculus) 6480464 Zearalenone results in increased expression of MAP1LC3B protein CTD PMID:34537261 zinc atom multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAP1LC3B mRNA CTD PMID:18593933 zinc oxide multiple interactions ISO Map1lc3b (Mus musculus) 6480464 MAP1LC3B mutant form inhibits the reaction [Zinc Oxide analog results in increased cleavage of CASP3 protein] CTD PMID:24614525 zinc oxide affects lipidation ISO MAP1LC3B (Homo sapiens) 6480464 Zinc Oxide affects the lipidation of MAP1LC3B protein CTD PMID:34766255 zinc oxide increases expression EXP 6480464 Zinc Oxide results in increased expression of MAP1LC3B mRNA and Zinc Oxide results in increased expression of MAP1LC3B protein CTD PMID:32951350 zinc oxide increases expression ISO MAP1LC3B (Homo sapiens) 6480464 Zinc Oxide results in increased expression of MAP1LC3B protein CTD PMID:29289694 zinc(0) multiple interactions ISO MAP1LC3B (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of MAP1LC3B mRNA CTD PMID:18593933